title: Why all women should freeze their eggs.
abstract: The use of oocyte cryopreservation via vitrification has increased lately, becoming a common strategy in many IVF centers. This review summarizes the current state of oocyte vitrification, by analyzing the most recent reports on its use in IVF as part of infertile treatment and its contribution to elective fertility preservation (EFP).
  
  
  
  Oocyte vitrification has become helpful for managing different clinical situations currently providing similar results to fresh oocytes. Owing to satisfactory results, oocyte vitrification is being offered to healthy women to extend their reproductive options (EFP). Although little is known about outcomes in this specific population, new evidence is starting to emerge. Currently, most women are motivated by age and lack of partner. Age is strongly related to the probability of having a child with better chances when they do EFP younger than 35. In contrast to the biological efficiency, the majority of studies show that EFP is more cost-effective at 37-38 years.
  
  
  
  Oocyte vitrification is an efficient tool which can be helpful in managing the IVF cycle. Fertility preservation providers should inform women about their specific probabilities according to their age at vitrification, making emphasis in the fact that egg freezing does not guarantee success, but increases the possibilities of having a biological child in the future.
authors.affiliation: aInstituto Valenciano de Infertilidad (IVI), Valencia bInstituto Valenciano de Infertilidad (IVI), Madrid, Spain.
authors.forename: Ana
authors.initials: A
authors.lastname: Cobo
authors.forename: Juan Antonio
authors.initials: JA
authors.lastname: García-Velasco
mesh_terms: D000328:Adult; D015925:Cryopreservation / Q000379:methods*; D005260:Female; D059247:Fertility Preservation; D005307:Fertilization in Vitro; D006801:Humans; D009865:Oocytes; D011247:Pregnancy; D018873:Pregnancy Rate; D027724:Reproductive Techniques, Assisted; D058989:Vitrification